Trials / Conditions / Pigment Epithelial Detachment
Pigment Epithelial Detachment
6 registered clinical trials studyying Pigment Epithelial Detachment.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Aflibercept in Patients With Pigment Epithelial Detachments (PED) NCT03370380 | University Hospital Muenster | — |
| Unknown | On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Det NCT01670162 | Tennessee Retina | Phase 4 |
| Terminated | iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular NCT01334255 | Lpath, Inc. | Phase 1 |
| Completed | Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments NCT00976222 | University Hospital Muenster | Phase 4 |
| Completed | Lucentis to Treat Pigment Epithelial Detachment NCT00841581 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 2 |
| Completed | Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments NCT00590694 | Pacific Eye Associates | Phase 2 / Phase 3 |